Genetically attenuated Plasmodium berghei liver stages persist and elicit sterile protection primarily via CD8 T cells

American Journal of Pathology

Volumn 171, Issue 1, 2007, Pages 107-115

  Mueller, Ann Kristin ^a   Deckert, Martina ^b   Heiss, Kirsten ^a   Goetz, Kristin ^a   Matuschewski, Kai ^a   Schlüter, Dirk ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; LIVE VACCINE; PARASITE ANTIBODY; PRIMAQUINE DERIVATIVE; PRIMAQUINE DIPHOSPHATE; RAG1 PROTEIN; SPOROZOITE VACCINE; UNCLASSIFIED DRUG; MALARIA VACCINE; PROTOZOON ANTIBODY;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DRUG MECHANISM; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; LIVER PARENCHYMA; LYMPHOCYTE DEPLETION; MALARIA; MOUSE; NONHUMAN; PARASITE; PARASITEMIA; PLASMODIUM BERGHEI; PRIORITY JOURNAL; PROTOZOAL INFECTION; SPLEEN CELL; SPOROZOITE; T LYMPHOCYTE; WILD TYPE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CD8+ T LYMPHOCYTE; GENE; GENETICS; IMMUNIZATION; IMMUNOLOGY; LIVER; MOUSE MUTANT; PARASITOLOGY;

ANIMALS; ANTIBODIES, PROTOZOAN; CD8-POSITIVE T-LYMPHOCYTES; GENES, PROTOZOAN; GENES, RAG-1; IMMUNIZATION; INTERFERON TYPE II; LIVER; MALARIA VACCINES; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PLASMODIUM BERGHEI; VACCINES, ATTENUATED;

EID: 34547699709     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.060792     Document Type: Article

References (32)

1. Nussenzweig RS, Vanderberg J, Most H, Orton C: Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. Nature 1967, 216:160-162
2. Clyde DF, Most H, McCarthy VC, Vanderberg JP: Immunization of man against sporozoite-induced falciparum malaria. Am J Med Sci 1973, 266:169-177
3. Hoffman SL, Goh LM, Luke TC, Schneider I, Le TP, Doolan DL, Sacci J, de la Vega P, Dowler M, Paul C, Gordon DM, Stoute JA, Church LW, Sedegah M, Heppner DG, Ballou WR, Richie TL: Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis 2002, 185:1155-1164
4. Mellouk S, Lunel F, Sedegah M, Beaudoin RL, Druilhe P: Protection against malaria induced by irradiated sporozoites. Lancet 1990, 335:721
5. Silvie O, Semblat JP, Franetich JF, Hannoun L, Eling W, Mazier D: Effects of irradiation on Plasmodium falciparum sporozoite hepatic development: implications for the design of pre-erythrocytic malaria vaccines. Parasite Immunol 2002, 24:221-223
6. + T cell responses against Plasmodium liver stages in mice. Int J Parasitol 2004, 34:1529-1534
7. Matuschewski K: Vaccine development against malaria. Curr Opin Immunol 2006, 18:449-457
8. Schofield L, Villaquiran J, Ferreira A, Schellekens H, Nussenzweig R, Nussenzweig V: Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 1987, 330:664-666
9. Weiss WR, Sedegah M, Beaudoin RL, Miller LH, Good MF: CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc Natl Acad Sci USA 1988, 85:573-576
10. Rodrigues M, Nussenzweig RS, Zavala F: The relative contribution of antibodies, CD4+ and CD8+ T cells to sporozoite-induced protection against malaria. Immunology 1993, 80:1-5
11. White KL, Snyder HL, Krzych U: MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei. J Immunol 1996, 156:3374-3381
12. Renggli J, Hahne M, Matile H, Betschart B, Tschopp J, Corradin G: Elimination of P. berghei liver stages is independent of Fas (CD95/ Apo-I) or perforin-mediated cytotoxicity. Parasite Immunol 1997, 19:145-158
13. Sano G, Hafalla JC, Morrot A, Abe R, Lafaille JJ, Zavala F: Swift development of protective effector functions in naive CD8(+) T cells against malaria liver stages. J Exp Med 2001, 194:173-180
14. Chen DH, Tigelaar RE, Weinbaum FI: Immunity to sporozoite-induced malaria infection in mice. I. The effect of immunization of T and B cell-deficient mice. J Immunol 1977, 118:1322-1327
15. Egan JE, Weber JL, Ballou WR, Hollingdale MR, Majarian WR, Gordon DM, Maloy WL, Hoffman SL, Wirtz RA, Schneider I: Efficacy of murine malaria sporozoite vaccines: implications for human vaccine development. Science 1987, 236:453-456
16. Scheller LF, Azad AF: Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sporozoites. Proc Natl Acad Sci USA 1995, 92:4066-4068
17. Guebre-Xabier M, Schwenk R, Krzych U: Memory phenotype CD8(+) T cells persist in livers of mice protected against malaria by immunization with attenuated Plasmodium berghei sporozoites. Eur J Immunol 1999, 29:3978-3986
18. Mueller AK, Labaied M, Kappe SH, Matuschewski K: Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 2005, 433:164-167
19. Mueller AK, Camargo N, Kaiser K, Andorfer C, Frevert U, Matuschewski K, Kappe SH: Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. Proc Natl Acad Sci USA 2005, 102:3022-3027
20. Waters AP, Mota MM, van Dijk MR, Janse CJ: Parasitology, Malaria vaccines: back to the future? Science 2005, 307:528-530
21. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE: RAG-1-deficient mice have no mature B and T lymphocytes. Cell 1992, 68:869-877
22. Kitamura D, Roes J, Kuhn R, Rajewsky K: A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 1991, 350:423-426
23. Schluter D, Lohler J, Deckert M, Hof H, Schwendemann G: Toxoplasma encephalitis of immunocompetent and nude mice: immunohistochemical characterisation of Toxoplasma antigen, infiltrates and major histocompatibility complex gene products. J Neuroimmunol 1991, 31:185-198
24. Berenzon D, Schwenk RJ, Letellier L, Guebre-Xabier M, Williams J, Krzych U: Protracted protection to Plasmodium berghei malaria is linked to functionally and phenotypically heterogeneous liver memory CD8+ T cells. J Immunol 2003, 171:2024-2034
25. Scheller LF, Wirtz RA, Azad AF: Susceptibility of different strains of mice to hepatic infection with Plasmodium berghei. Infect Immun 1994, 62:4844-4847
26. Rodrigues MM, Cordey AS, Arreaza G, Corradin G, Romero P, Maryanski JL, Nussenzweig RS, Zavala F: CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. Int Immunol 1991, 3:579-585
27. Romero P, Maryanski JL, Corradin G, Nussenzweig RS, Nussenzweig V, Zavala F: Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 1989, 341:323-326
28. Deckert M, Soltek S, Geginat G, Lütjen S, Montesinos-Rongen M, Hof H, Schlüter D: Endogenous interleukin-10 is required for prevention of a hyperinflammatory intracerebral immune response in Listeria monocytogenes meningoencephalitis. Infect Immun 2001, 69:4561-4571
29. Geginat G, Schenk S, Skoberne M, Goebel W, Hof H: A novel approach of direct ex vivo epitope mapping identifies dominant and subdominant CD4 and CD8 T cell epitopes from Listeria monocytogenes. J Immunol 2001, 166:1877-1884
30. Good MF: Genetically modified Plasmodium highlights the potential of whole parasite vaccine strategies. Trends Immunol 2005, 26:295-297
31. Spitalny GL, Verhave JP, Meuwissen JH, Nussenzweig RS: Plasmodium berghei: T cell dependence of sporozoite-induced immunity in rodents. Exp Parasitol 1977, 42:73-81
32. Kumar KA, Sano G, Boscardin S, Nussenzweig RS, Nussenzweig MC, Zavala F, Nussenzweig V: The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature 2006, 444:937-940